Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/brain/awac379
PubMed Identifier: 36256599
Publication URI: http://europepmc.org/abstract/MED/36256599
Type: Journal Article/Review
Parent Publication: Brain
Issue: 2
ISSN: 0006-8950